Emergence of cross-resistance to beta-lactam antibiotics in fecal Escherichia coli and Klebsiella strains from neonates treated with ampicillin or cefuroxime
- 1 February 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (2) , 361-362
- https://doi.org/10.1128/aac.34.2.361
Abstract
Both ampicillin and cefuroxime therapy of neonates selected drug- and species-dependent beta-lactam resistance patterns in fecal strains of Escherichia coli and Klebsiella spp. This was in contrast to our previous findings that ampicillin, but not cefuroxime, contributed to the emergence of beta-lactam resistance also by the promotion of nosocomial spread of resistant strains.This publication has 9 references indexed in Scilit:
- ECOLOGICAL IMPACT OF AMPICILLIN AND CEFUROXIME IN NEONATAL UNITSThe Lancet, 1989
- Epidemiology of fecal strains of the family Enterobacteriaceae in 22 neonatal wards and influence of antibiotic policyJournal of Clinical Microbiology, 1988
- Influence of age on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in hospitalized neonatesJournal of Hospital Infection, 1988
- Investigation of the biliary clearances of cefotaxime and desacetylcefotaxime by an original procedure in cholecystectomised patientsInfection, 1987
- Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unitAntimicrobial Agents and Chemotherapy, 1986
- Endemic Emergence of Cephalosporin-Resistant Enterobacter: Relation to Prior TherapyInfection Control & Hospital Epidemiology, 1986
- Selection of beta-lactamase producers during cephalosporin and penicillin therapy.1986
- Biochemical fingerprinting of Escherichia coli: a simple method for epidemiological investigationsJournal of Microbiological Methods, 1985